Liquid Biopsy Market Size, Share and Forecast 2018-2023

Posted by Rishabh on August 28th, 2019

“Shifting paradigms in cancer treatment to increase the demand of liquid biopsy”

Orion Market Research (OMR) recently published a market research report on the global liquid biopsy market.  According to OMR analysis, the global liquid biopsy market is estimated to grow with a significant CAGR during the forecast period, 2018-2023. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market.

Full report of Global Liquid BiopsyMarket is available at:https://www.omrglobal.com/industry-reports/liquid-biopsy-market/  

Furthermore, the global liquid biopsy market is segmented on the basis of biomarker type, cancer type, end-user and regional outlook. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

Global Liquid Biopsy Market by Biomarker Type

• Circulating Tumor Cells
• Circulating Tumor DNA (ctDNA)
• Others (Extracellular Vesicles)

Global Liquid Biopsy Market by Cancer Type

• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Other Cancers

Global Liquid Biopsy Market by End-User

• Hospitals and Laboratories
• Academic and Research Centre

Region Covered

• North America (US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the Word (the Middle East & Africa and Latin America)

Company Profiled

• Biocept, Inc.
• Biodesix, Inc.
• Bio-Rad Laboratories, Inc.
• CellMax Life
• Circulogene
• Clearbridge Biomedics Pte Ltd.
• Cynvenio Biosystems, Inc.
• Epigenomics AG
• Exosome Diagnostics, Inc.
• F. Hoffmann-La Roche AG
• Genomic Health, Inc.
• Guardant Health, Inc.

Request a free sample of our report on Global Liquid BiopsyMarket: https://www.omrglobal.com/request-sample/liquid-biopsy-market

The key questions answered in the Liquid BiopsyMarket study:

• To analyze the Liquid Biopsy Market size (values and volume) by Biomarker Type, cancer, end-user with historical data of 2017 and 2018 and forecast to 2023.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze the Liquid Biopsy Market growth, global trends, future prospectus and contribution to the market. 

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404